vs

Side-by-side financial comparison of Celanese Corp (CE) and Synopsys (SNPS). Click either name above to swap in a different company.

Synopsys is the larger business by last-quarter revenue ($2.3B vs $2.2B, roughly 1.0× Celanese Corp). Synopsys runs the higher net margin — 19.9% vs 0.6%, a 19.3% gap on every dollar of revenue. On growth, Synopsys posted the faster year-over-year revenue change (50.6% vs -7.0%). Synopsys produced more free cash flow last quarter ($605.2M vs $168.0M). Over the past eight quarters, Synopsys's revenue compounded faster (16.9% CAGR vs -8.1%).

Celanese Corporation, formerly known as Hoechst Celanese, is an American technology and specialty materials company headquartered in Irving, Texas. It is a Fortune 500 corporation. The company is the world's leading producer of acetic acid, producing about 1.95 million tonnes per year, representing approximately 20% of global production. Celanese is also the world's largest producer of vinyl acetate monomer (VAM).

Synopsys, Inc. is an American multinational electronic design automation (EDA) company headquartered in Sunnyvale, California, that focuses on design and verification of silicon chips, electronic system-level design and verification, and reusable components. Synopsys supplies tools and services to the semiconductor design and manufacturing industry.

CE vs SNPS — Head-to-Head

Bigger by revenue
SNPS
SNPS
1.0× larger
SNPS
$2.3B
$2.2B
CE
Growing faster (revenue YoY)
SNPS
SNPS
+57.6% gap
SNPS
50.6%
-7.0%
CE
Higher net margin
SNPS
SNPS
19.3% more per $
SNPS
19.9%
0.6%
CE
More free cash flow
SNPS
SNPS
$437.2M more FCF
SNPS
$605.2M
$168.0M
CE
Faster 2-yr revenue CAGR
SNPS
SNPS
Annualised
SNPS
16.9%
-8.1%
CE

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CE
CE
SNPS
SNPS
Revenue
$2.2B
$2.3B
Net Profit
$14.0M
$448.7M
Gross Margin
19.1%
71.0%
Operating Margin
4.0%
5.4%
Net Margin
0.6%
19.9%
Revenue YoY
-7.0%
50.6%
Net Profit YoY
100.7%
-59.7%
EPS (diluted)
$0.13
$2.44

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CE
CE
SNPS
SNPS
Q4 25
$2.2B
$2.3B
Q3 25
$2.4B
$1.7B
Q2 25
$2.5B
$1.6B
Q1 25
$2.4B
$1.5B
Q4 24
$2.4B
$1.5B
Q3 24
$2.6B
$1.5B
Q2 24
$2.7B
$1.5B
Q1 24
$2.6B
$1.6B
Net Profit
CE
CE
SNPS
SNPS
Q4 25
$14.0M
$448.7M
Q3 25
$-1.4B
$242.5M
Q2 25
$199.0M
$345.3M
Q1 25
$-21.0M
$295.7M
Q4 24
$-1.9B
$1.1B
Q3 24
$116.0M
$408.1M
Q2 24
$155.0M
$292.1M
Q1 24
$121.0M
$449.1M
Gross Margin
CE
CE
SNPS
SNPS
Q4 25
19.1%
71.0%
Q3 25
21.5%
78.1%
Q2 25
21.1%
80.2%
Q1 25
19.9%
81.4%
Q4 24
22.7%
78.3%
Q3 24
23.5%
80.9%
Q2 24
24.2%
79.4%
Q1 24
21.2%
80.0%
Operating Margin
CE
CE
SNPS
SNPS
Q4 25
4.0%
5.4%
Q3 25
-52.7%
9.5%
Q2 25
9.2%
23.5%
Q1 25
7.0%
17.3%
Q4 24
-59.3%
20.3%
Q3 24
9.4%
23.6%
Q2 24
9.4%
22.8%
Q1 24
8.0%
21.8%
Net Margin
CE
CE
SNPS
SNPS
Q4 25
0.6%
19.9%
Q3 25
-56.1%
13.9%
Q2 25
7.9%
21.5%
Q1 25
-0.9%
20.3%
Q4 24
-80.8%
74.4%
Q3 24
4.4%
26.7%
Q2 24
5.8%
20.1%
Q1 24
4.6%
27.2%
EPS (diluted)
CE
CE
SNPS
SNPS
Q4 25
$0.13
$2.44
Q3 25
$-12.39
$1.50
Q2 25
$1.81
$2.21
Q1 25
$-0.19
$1.89
Q4 24
$-17.50
$7.13
Q3 24
$1.06
$2.61
Q2 24
$1.41
$1.88
Q1 24
$1.10
$2.89

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CE
CE
SNPS
SNPS
Cash + ST InvestmentsLiquidity on hand
$3.0B
Total DebtLower is stronger
$11.4B
$13.5B
Stockholders' EquityBook value
$4.0B
$28.3B
Total Assets
$21.7B
$48.2B
Debt / EquityLower = less leverage
2.81×
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CE
CE
SNPS
SNPS
Q4 25
$3.0B
Q3 25
$2.6B
Q2 25
$14.3B
Q1 25
$3.8B
Q4 24
$4.1B
Q3 24
$2.0B
Q2 24
$1.7B
Q1 24
$1.3B
Total Debt
CE
CE
SNPS
SNPS
Q4 25
$11.4B
$13.5B
Q3 25
$11.7B
$14.3B
Q2 25
$12.7B
$10.1B
Q1 25
$12.4B
Q4 24
$11.1B
Q3 24
$11.3B
Q2 24
$11.1B
Q1 24
$11.0B
Stockholders' Equity
CE
CE
SNPS
SNPS
Q4 25
$4.0B
$28.3B
Q3 25
$4.0B
$27.6B
Q2 25
$5.3B
$9.9B
Q1 25
$5.2B
$9.3B
Q4 24
$5.2B
$9.0B
Q3 24
$7.3B
$7.7B
Q2 24
$7.2B
$7.2B
Q1 24
$7.1B
$6.7B
Total Assets
CE
CE
SNPS
SNPS
Q4 25
$21.7B
$48.2B
Q3 25
$22.2B
$48.2B
Q2 25
$23.7B
$23.8B
Q1 25
$23.2B
$13.0B
Q4 24
$22.9B
$13.1B
Q3 24
$25.9B
$11.6B
Q2 24
$25.8B
$11.0B
Q1 24
$26.0B
$10.6B
Debt / Equity
CE
CE
SNPS
SNPS
Q4 25
2.81×
0.48×
Q3 25
2.95×
0.52×
Q2 25
2.41×
1.01×
Q1 25
2.39×
Q4 24
2.14×
Q3 24
1.56×
Q2 24
1.54×
Q1 24
1.56×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CE
CE
SNPS
SNPS
Operating Cash FlowLast quarter
$252.0M
$639.7M
Free Cash FlowOCF − Capex
$168.0M
$605.2M
FCF MarginFCF / Revenue
7.6%
26.8%
Capex IntensityCapex / Revenue
3.8%
1.5%
Cash ConversionOCF / Net Profit
18.00×
1.43×
TTM Free Cash FlowTrailing 4 quarters
$803.0M
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CE
CE
SNPS
SNPS
Q4 25
$252.0M
$639.7M
Q3 25
$447.0M
$671.0M
Q2 25
$410.0M
$275.4M
Q1 25
$37.0M
$-67.5M
Q4 24
$494.0M
$562.8M
Q3 24
$79.0M
$455.4M
Q2 24
$292.0M
$476.6M
Q1 24
$101.0M
$-87.8M
Free Cash Flow
CE
CE
SNPS
SNPS
Q4 25
$168.0M
$605.2M
Q3 25
$383.0M
$632.4M
Q2 25
$317.0M
$219.8M
Q1 25
$-65.0M
$-108.2M
Q4 24
$389.0M
$558.4M
Q3 24
$-9.0M
$415.4M
Q2 24
$187.0M
$438.2M
Q1 24
$-36.0M
$-128.2M
FCF Margin
CE
CE
SNPS
SNPS
Q4 25
7.6%
26.8%
Q3 25
15.8%
36.3%
Q2 25
12.5%
13.7%
Q1 25
-2.7%
-7.4%
Q4 24
16.4%
37.3%
Q3 24
-0.3%
27.2%
Q2 24
7.1%
30.1%
Q1 24
-1.4%
-7.8%
Capex Intensity
CE
CE
SNPS
SNPS
Q4 25
3.8%
1.5%
Q3 25
2.6%
2.2%
Q2 25
3.7%
3.5%
Q1 25
4.3%
2.8%
Q4 24
4.4%
0.3%
Q3 24
3.3%
2.6%
Q2 24
4.0%
2.6%
Q1 24
5.2%
2.4%
Cash Conversion
CE
CE
SNPS
SNPS
Q4 25
18.00×
1.43×
Q3 25
2.77×
Q2 25
2.06×
0.80×
Q1 25
-0.23×
Q4 24
0.51×
Q3 24
0.68×
1.12×
Q2 24
1.88×
1.63×
Q1 24
0.83×
-0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CE
CE

Engineered Materials$1.3B58%
Acetyl Chain$940.0M43%

SNPS
SNPS

License And Maintenance$940.7M42%
Other$640.0M28%
Design IP Segment$407.1M18%
KR$236.9M11%
Sales Based Royalties$30.1M1%

Related Comparisons